Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
194
Historia
147
Política y gobierno
74
Impuestos
68
Impuestos sobre la renta
41
Derecho fiscal
26
Derecho civil
25
Industria de la construcción
16
Condiciones económicas
15
Seguridad social
15
Derecho constitucional
13
Democracia
12
Derecho laboral
12
Condiciones sociales
11
México
11
Elecciones
10
Legislación
9
Partidos políticos
9
Regulación del comercio exterior
9
Colonias
8
Derecho administrativo
8
Educación
8
Historia constitucional
8
Impuesto sobre el valor agregado
8
Agricultura
7
Aranceles de aduana
7
Causas
7
Derecho
7
Función pública
7
Impuesto al valor agregado
7
-
59461por Gebbers, Narcisa, Hirt-Burri, Nathalie, Scaletta, Corinne, Hoffmann, Gerd, Applegate, Lee Ann“…Both conventional Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and quantitative real-time RT-PCR techniques were used to determine the induction of MMP-1 mRNA at two physiologic temperatures for skin fibroblasts (30°C and 37°C) in single exposure regimens (15-60 minutes wIRA(+RL), 340-1360 J/cm² wIRA(+RL), 300-1200 J/cm² wIRA; 30 minutes UV-A(+BL), 50 J/cm² UV-A(+BL)) and in addition at 30°C in a repeated exposure protocol (up to 10 times 15 minutes wIRA(+RL) with 340 J/cm² wIRA(+RL), 300 J/cm² wIRA at each time). …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Texto -
59462“…Preliminary work has focused on substitution of generic simvastatin for branded Zocor. As TB treatment regimens usually include a fixed set of medications (isoniazid, rifampin, pyrazinamide, ethambutol), the utilization of these drugs should correspond with TB incidence. …”
Enlace del recurso
Online Artículo Texto -
59463“…Pubertate males with lymphoma and leukemia who have objections to retrieving ejaculate through masturbation (ethical, religious, etc.) should be considered for electroejaculation under general anesthesia. Chemotherapy regimens avoiding alkylating agents result in reducing irreversible sperm damage rate from 60% to 8%. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59464por Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S W, Felip, Enriqueta, Chow, Laura Q M, Camidge, D Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J, Solomon, Benjamin J, Wolf, Jürgen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Sutradhar, Santosh, Li, Siyu, Szczudlo, Tomasz, Yovine, Alejandro, Shaw, Alice T“…Patients were mainly heavily pretreated (105/246 [42·7%] at least three prior regimens). The overall response rate was 72·3% (60/83; 95% confidence interval [CI] 61·4–81·6) for ALKi-naïve (n=83) and 56·4% (92/163; 95% CI 48·5–64·2) for ALKi-pretreated (n=163) patients. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59465por Tang, Lydia Shuk Yee, Masur, Jack, Sims, Zayani, Nelson, Amy, Osinusi, Anu, Kohli, Anita, Kattakuzhy, Sarah, Polis, Michael, Kottilil, Shyam“…Patients were treated for HCV with 3 different regimens: Sofosbuvir and ribavirin in the SPARE trial, ledipasvir and sofosbuvir in SYNERGY-A and ERADICATE trials, and pegylated interferon (IFN) and ribavirin for 48 wk in the PIFNPK and ALBIN trials. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59466por Crowther, Caroline A., Middleton, Philippa F., Voysey, Merryn, Askie, Lisa, Duley, Lelia, Pryde, Peter G., Marret, Stéphane, Doyle, Lex W.“…Benefit is seen regardless of the reason for preterm birth, with similar effects across a range of preterm gestational ages and different treatment regimens. Widespread adoption worldwide of this relatively inexpensive, easy-to-administer treatment would lead to important global health benefits for infants born preterm.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59467por Lodise, Thomas P, Rosenkranz, Susan L, Finnemeyer, Matthew, Huvane, Jacqueline, Pereira, Alenda, Sims, Matthew, Zervos, Marcus J, Creech, C Buddy, Patel, Pratish C, Keefer, Michael, Riska, Paul, Silveira, Fernanda P, Scheetz, Marc, Wunderink, Richard G, Rodriguez, Martin, Schrank, John, Bleasdale, Susan C, Schultz, Sara, Barron, Michelle, Stapleton, Ann, Chambers, H, Fowler, Vance, Holland, Thomas L“…Clinicians should assess the benefits vs. risks of using VAN regimens that confer high AUC(DAY2)/MIC exposures for patients with MRSA BSIs. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59468“…Precision techniques offer medical and public health practitioners the opportunity to personally tailor preventive and therapeutic regimens based on informatics applied to large volume genotypic and phenotypic data. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59469por Kim, Jason, Nakwa, Firdose Lambey, Motta, Fábio De Araujo, Lozada, Perla Salcedo, Alabaz, Derya, Liu, Hong, Bloise, Keisha, Dorr, Mary Beth, Gaffney, Leah J Anderson, Kartsonis, Nicholas“…BACKGROUND: Candida species are the most common fungal pathogens in infants aged <1 year. Current antifungal regimens such as amphotericin B deoxycholate (dAmB) are associated with serious toxicity and multiple drug-drug interactions. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59470por Lenguerrand, Erik, Whitehouse, Michael R, Beswick, Andrew D, Kunutsor, Setor K, Foguet, Pedro, Porter, Martyn, Blom, Ashley W“…Non-modifiable factors and the time-specific nature of the effects we have observed will allow clinicians to appropriately counsel patients preoperatively and tailor follow-up regimens. FUNDING: National Institute for Health Research.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59471por Sannino, Giuseppina, Marchetto, Aruna, Ranft, Andreas, Jabar, Susanne, Zacherl, Constanze, Alba-Rubio, Rebeca, Stein, Stefanie, Wehweck, Fabienne S., Kiran, Merve M., Hölting, Tilman L.B., Musa, Julian, Romero-Pérez, Laura, Cidre-Aranaz, Florencia, Knott, Maximilian M.L., Li, Jing, Jürgens, Heribert, Sastre, Ana, Alonso, Javier, Da Silveira, Willian, Hardiman, Gary, Gerke, Julia S., Orth, Martin F., Hartmann, Wolfgang, Kirchner, Thomas, Ohmura, Shunya, Dirksen, Uta, Grünewald, Thomas G.P.“…This is in part caused by the absence of prognostic biomarkers that can identify high-risk patients and thus assign them to risk-adapted monitoring and treatment regimens. Since cancer stemness has been associated with tumour relapse and poor patient outcomes, we investigated in the current study the prognostic potential SOX2 (sex determining region Y box 2) – a major transcription factor involved in development and stemness – which was previously described to contribute to the undifferentiated phenotype of EwS. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59472por Carrasco, Joao, Pietsch, Georg-Alexander, Nicolas, Marie-Pierre, Koerber, Cecile, Bennison, Craig, Yoon, Jisu“…On average, RBZ-treated patients reported a low injection frequency and a frequent follow-up, driven in part by the high number of patients treated with pro re nata (PRN) regimens. RBZ-treated patients reported gains in VA versus baseline; however, the magnitude of the gain in VA was not comparable to the VA gains reported in the RBZ pivotal RCT. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59473por Liu, Wei, Tao, Zhao-Wu, Wang, Lei, Yuan, Ming-Li, Liu, Kui, Zhou, Ling, Wei, Shuang, Deng, Yan, Liu, Jing, Liu, Hui-Guo, Yang, Ming, Hu, Yi“…Associated results will be used to evaluate the prognosis and to find the optimal treatment regimens for COVID-19 pneumonia. METHODS: Patients tested positive for the COVID-19 based on nucleic acid detection were included in this study. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59474por Conterno, Lucieni O, Turchi, Marilia D, Corrêa, Ione, Monteiro de Barros Almeida, Ricardo Augusto“…There is little to choose between drugs and regimens in terms of cure or adverse events.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59475por Blagden, Sarah P, Cook, Adrian D, Poole, Christopher, Howells, Lesley, McNeish, Ian A, Dean, Andrew, Kim, Jae-Weon, O'Donnell, Dearbhaile M, Hook, Jane, James, Elizabeth C, White, Ian R, Perren, Timothy, Lord, Rosemary, Dark, Graham, Earl, Helena M, Hall, Marcia, Kaplan, Richard, Ledermann, Jonathan A, Clamp, Andrew R“…Taken together with the lack of progression-free survival benefit, these findings do not support routine use of weekly paclitaxel-containing regimens in the management of newly diagnosed ovarian cancer. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59476por VanScoy, Brian D, Fikes, Steven, Rubino, Christopher M, Bhavnani, Sujata M, Cotroneo, Nicole S, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G“…Two hours post-incubation, 8 total daily tebipenem HBr doses (0.3 to 135 mg/kg) were fractionated into regimens given every 8 hours. The relationship between change in log(10) CFU/g from baseline at 24 hours and free-drug plasma AUC:MIC ratio•1/τ was fit using a Hill-type model. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59477por Iwalokun, Bamidele Abiodun, Olalekan, Adesola, Adenipekun, Eyitayo, Ojo, Olabisi, Iwalokun, Senapon Olusola, Mutiu, Bamidele, Orija, Oluseyi, Adegbola, Richard, Salako, Babatunde, Akinloye, Oluyemi“…Understanding the interplay of these determinants in the context of lymphopenia and COVID-19 complications in patients in Africa may help with risk stratification and appropriate deployment of targeted treatment regimens with repurposed drugs to improve prognosis. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59478por He, Xin, Sarafoglou, Kyriakie, Fechner, Patricia Y, Vogiatzi, Maria George, Imel, Erik Allen, Davis, Shanlee Marie, Sturgeon, Julia, Chan, Jean Lin, Farber, Robert, Auchus, Richard Joseph“…Methods: A4 and T data were analyzed for 7 men who completed 1 or more of 4 oral dosing regimens: Cohort 1, 50 mg QHS, n=4; Cohort 2, 100 mg QHS, n=2; Cohort 3, 100 mg QPM, n=5; and Cohort 4, 100 mg BID, n=3 (14 total treatment periods). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59479Publicado 2021“…METHODS: We did a meta-analysis of individual participant-level data from 48 randomised trials of pharmacological blood pressure lowering medications versus placebo or other classes of blood pressure-lowering medications, or between more versus less intensive treatment regimens, which had at least 1000 persons-years of follow-up in each group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59480“…Patient expressed preference/satisfaction and willingness to continue with home-based regimens; while methodologies varied among studies, 70% to 100% of patients preferred home administration. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto